Forbes W - Search Results

1

Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.

Pimentel M, Morales W, Rezaie A, Marsh E, Lembo A, Mirocha J, Leffler DA, Marsh Z, Weitsman S, Chua KS, Barlow GM, Bortey E, Forbes W, Yu A, Chang C. Pimentel M, et al. Among authors: forbes w. PLoS One. 2015 May 13;10(5):e0126438. doi: 10.1371/journal.pone.0126438. eCollection 2015. PLoS One. 2015. PMID: 25970536 Free PMC article.

2

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP; TARGET Study Group. Pimentel M, et al. N Engl J Med. 2011 Jan 6;364(1):22-32. doi: 10.1056/NEJMoa1004409. N Engl J Med. 2011. PMID: 21208106 Free article. Clinical Trial.

3

Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.

Lembo A, Pimentel M, Rao SS, Schoenfeld P, Cash B, Weinstock LB, Paterson C, Bortey E, Forbes WP. Lembo A, et al. Among authors: forbes wp. Gastroenterology. 2016 Dec;151(6):1113-1121. doi: 10.1053/j.gastro.2016.08.003. Epub 2016 Aug 13. Gastroenterology. 2016. PMID: 27528177 Free article. Clinical Trial.

4

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials.

Schoenfeld P, Pimentel M, Chang L, Lembo A, Chey WD, Yu J, Paterson C, Bortey E, Forbes WP. Schoenfeld P, et al. Among authors: forbes wp. Aliment Pharmacol Ther. 2014 May;39(10):1161-8. doi: 10.1111/apt.12735. Epub 2014 Apr 3. Aliment Pharmacol Ther. 2014. PMID: 24697851 Free PMC article.

5

Long-term safety and tolerability of once-daily mesalamine granules in the maintenance of remission of ulcerative colitis.

Lichtenstein GR, Barrett AC, Bortey E, Paterson C, Forbes WP. Lichtenstein GR, et al. Inflamm Bowel Dis. 2014 Aug;20(8):1399-406. doi: 10.1097/MIB.0000000000000076. Inflamm Bowel Dis. 2014. PMID: 24874460 Clinical Trial.

6

Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study.

Macarthur RD, Hawkins TN, Brown SJ, Lamarca A, Clay PG, Barrett AC, Bortey E, Paterson C, Golden PL, Forbes WP. Macarthur RD, et al. HIV Clin Trials. 2013 Nov-Dec;14(6):261-73. doi: 10.1310/hct1406-261. HIV Clin Trials. 2013. PMID: 24334179 Clinical Trial.

7

Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy.

Mullen KD, Sanyal AJ, Bass NM, Poordad FF, Sheikh MY, Frederick RT, Bortey E, Forbes WP. Mullen KD, et al. Clin Gastroenterol Hepatol. 2014 Aug;12(8):1390-7.e2. doi: 10.1016/j.cgh.2013.12.021. Epub 2013 Dec 21. Clin Gastroenterol Hepatol. 2014. PMID: 24365449 Free article. Clinical Trial.

8

Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain.

Webster LR, Brenner DM, Barrett AC, Paterson C, Bortey E, Forbes WP. Webster LR, et al. J Pain Res. 2015 Oct 30;8:771-80. doi: 10.2147/JPR.S88203. eCollection 2015. J Pain Res. 2015. PMID: 26586963 Free PMC article.

9

Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.

Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Rubin DT, et al. Among authors: forbes wp. J Crohns Colitis. 2017 Jul 1;11(7):785-791. doi: 10.1093/ecco-jcc/jjx032. J Crohns Colitis. 2017. PMID: 28333362 Free PMC article. Clinical Trial.

10

Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.

Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Rubin DT, et al. Among authors: forbes wp. J Crohns Colitis. 2017 Dec 4;11(12):1510. doi: 10.1093/ecco-jcc/jjx052. J Crohns Colitis. 2017. PMID: 28453665 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page